Genes of the HOX4 paralog group have been shown to expand hematopoietic stem cells (HSCs). Endogenous expression of HOXA4 is 10-fold higher than HOXB4 in embryonic primitive hematopoietic cells undergoing self-renewal suggesting a more potent capacity of HOXA4 to expand HSC. In this study, we provide evidence by direct competitive bone marrow cultures that HOXA4 and HOXB4 induce self-renewal of primitive hematopoietic cells with identical kinetics. Transplantation assays show that short-term repopulation by HOXA4-overexpressing multilineage progenitors was significantly greater than HOXB4-overexpressing progenitors in vivo, indicating differences in the sensitivity of the cells to external signals. Small array gene expression analysis showed an increase in multiple Notch and Wnt signaling -associated genes, including receptors and ligands, as well as pluripotency genes, for both HOXA4- and HOXB4-overexpressing cells, which was more pronounced for HOXA4, suggesting that both HOX proteins may assert their affects through intrinsic and extrinsic pathways to induce self-renewal of primitive hematopoietic cells. Thus, HOXA4 increases short-term repopulation to higher levels than HOXB4, which may involve Notch signaling.
Get full access to this article
View all access options for this article.
References
1.
AlharbiRA, PettengellR, PandhaHS and MorganR. (2013). The role of HOX genes in normal hematopoiesis and acute leukemia. Leukemia, 27:1000–1008.
2.
SauvageauG, ThorsteinsdottirU, EavesCJ, LawrenceHJ, LargmanC, LansdorpPM and HumphriesRK. (1995). Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev, 9:1753–1765.
3.
SchiedlmeierB, KlumpH, WillE, Arman-KalcekG, LiZ, WangZ, RimekA, FrielJ, BaumC and OstertagW. (2003). High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34 + cells, but impairs lymphomyeloid differentiation. Blood, 101:1759–1768.
4.
AmsellemS, PflumioF, BardinetD, IzacB, CharneauP, RomeoPH, Dubart-KupperschmittA and FichelsonS. (2003). Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein. Nat Med, 9:1423–1427.
5.
KroslJ, AustinP, BesluN, KroonE, HumphriesRK and SauvageauG. (2003). In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Nat Med, 9:1428–1432.
6.
FournierM, Lebert-GhaliCE, KroslG and BijlJJ. (2012). HOXA4 induces expansion of hematopoietic stem cells in vitro and confers enhancement of pro-B-cells in vivo. Stem Cells Dev, 21:133–142.
7.
AntonchukJ, SauvageauG and HumphriesRK. (2002). HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell, 109:39–45.
8.
IacovinoM, HernandezC, XuZ, BajwaG, PratherM and KybaM. (2009). A conserved role for Hox paralog group 4 in regulation of hematopoietic progenitors. Stem Cells Dev, 18:783–792.
9.
AuvrayC, DelahayeA, PflumioF, HaddadR, AmsellemS, Miri-NezhadA, BroixL, YaciaA, BulleF, FichelsonS and VigonI. (2012). HOXC4 homeoprotein efficiently expands human hematopoietic stem cells and triggers similar molecular alterations as HOXB4. Haematologica, 97:168–178.
10.
GreerJM, PuetzJ, ThomasKR and CapecchiMR. (2000). Maintenance of functional equivalence during paralogous Hox gene evolution. Nature, 403:661–665.
11.
HoranGS, Ramirez-SolisR, FeatherstoneMS, WolgemuthDJ, BradleyA and BehringerRR. (1995). Compound mutants for the paralogous hoxa-4, hoxb-4, and hoxd-4 genes show more complete homeotic transformations and a dose-dependent increase in the number of vertebrae transformed. Genes Dev, 9:1667–1677.
12.
JordanCT and LemischkaIR. (1990). Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Dev, 4:220–232.
13.
BijlJ, ThompsonA, Ramirez-SolisR, KroslJ, GrierDG, LawrenceHJ and SauvageauG. (2006). Analysis of HSC activity and compensatory Hox gene expression profile in Hoxb cluster mutant fetal liver cells. Blood, 108:116–122.
14.
Lebert-GhaliCE, FournierM, DicksonGJ, ThompsonA, SauvageauG and BijlJJ. (2010). HoxA cluster is haploinsufficient for activity of hematopoietic stem and progenitor cells. Exp Hematol, 38:1074–1086.e1–e5.
15.
PineaultN, HelgasonCD, LawrenceHJ and HumphriesRK. (2002). Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny. Exp Hematol, 30:49–57.
16.
SauvageauG, LansdorpPM, EavesCJ, HoggeDE, DragowskaWH, ReidDS, LargmanC, LawrenceHJ and HumphriesRK. (1994). Differential expression of homeobox genes in functionally distinct CD34 + subpopulations of human bone marrow cells. Proc Natl Acad Sci U S A, 91:12223–12227.
17.
MarkowitzD, HesdorfferC, WardM, GoffS and BankA. (1990). Retroviral gene transfer using safe and efficient packaging cell lines. Ann N Y Acad Sci, 612:407–414.
18.
RothV. (2006). Doubling time. Available at: www.doubling-time.com/compute.php. Accessed 2014.
19.
HumphriesRK, EavesAC and EavesCJ. (1981). Self-renewal of hemopoietic stem cells during mixed colony formation in vitro. Proc Natl Acad Sci U S A, 78:3629–3633.
20.
DicksonGJ, LappinTR and ThompsonA. (2009). Complete array of HOX gene expression by RQ-PCR. Methods Mol Biol, 538:369–393.
21.
ThompsonA, QuinnMF, GrimwadeD, O'NeillCM, AhmedMR, GrimesS, McMullinMF, CotterF and LappinTR. (2003). Global down-regulation of HOX gene expression in PML-RARalpha + acute promyelocytic leukemia identified by small-array real-time PCR. Blood, 101:1558–1565.
22.
WangX, SpandidosA, WangH and SeedB. (2012). PrimerBank: a PCR primer database for quantitative gene expression analysis, 2012 update. Nucleic Acids Res, 40:D1144–D1149.
23.
DeneaultE, WilhelmBT, BergeronA, BarabeF and SauvageauG. (2013). Identification of non-cell-autonomous networks from engineered feeder cells that enhance murine hematopoietic stem cell activity. Exp Hematol, 41:470–478.e4.
24.
OshimaM, EndohM, EndoTA, ToyodaT, Nakajima-TakagiY, SugiyamaF, KosekiH, KybaM, IwamaA and OsawaM. (2011). Genome-wide analysis of target genes regulated by HoxB4 in hematopoietic stem and progenitor cells developing from embryonic stem cells. Blood, 117:e142–e150.
25.
OhP, LobryC, GaoJ, TikhonovaA, LoizouE, ManentJ, van HandelB, IbrahimS, GreveJ, et al. (2013). In vivo mapping of notch pathway activity in normal and stress hematopoiesis. Cell Stem Cell, 13:190–204.
26.
ChallenGA, BolesNC, ChambersSM and GoodellMA. (2010). Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-beta1. Cell Stem Cell, 6:265–278.
27.
JacksonM, AxtonRA, TaylorAH, WilsonJA, Gordon-KeylockSA, KokkaliarisKD, BrickmanJM, SchulzH, HummelO, HubnerN and ForresterLM. (2012). HOXB4 can enhance the differentiation of embryonic stem cells by modulating the hematopoietic niche. Stem Cells, 30:150–160.
28.
GuiuJ, ShimizuR, D'AltriT, FraserST, HatakeyamaJ, BresnickEH, KageyamaR, DzierzakE, YamamotoM, EspinosaL and BigasA. (2013). Hes repressors are essential regulators of hematopoietic stem cell development downstream of Notch signaling. J Exp Med, 210:71–84.
29.
StierS, ChengT, DombkowskiD, CarlessoN and ScaddenDT. (2002). Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood, 99:2369–2378.
30.
Varnum-FinneyB, Brashem-SteinC and BernsteinID. (2003). Combined effects of Notch signaling and cytokines induce a multiple log increase in precursors with lymphoid and myeloid reconstituting ability. Blood, 101:1784–1789.
31.
Varnum-FinneyB, PurtonLE, YuM, Brashem-SteinC, FlowersD, StaatsS, MooreKA, Le RouxI, MannR, et al. (1998). The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells. Blood, 91:4084–4091.
32.
WattsKL, DelaneyC, HumphriesRK, BernsteinID and KiemHP. (2010). Combination of HOXB4 and Delta-1 ligand improves expansion of cord blood cells. Blood, 116:5859–5866.
33.
WattsKL, DelaneyC, NelsonV, TrobridgeGD, BeardBC, HumphriesRK and KiemHP. (2013). CD34(+) expansion with Delta-1 and HOXB4 promotes rapid engraftment and transfusion independence in a Macaca nemestrina cord blood transplant model. Mol Ther, 21:1270–1278.
34.
CordesR, Schuster-GosslerK, SerthK and GosslerA. (2004). Specification of vertebral identity is coupled to Notch signalling and the segmentation clock. Development, 131:1221–1233.
35.
SenguptaA, BanerjeeD, ChandraS, BanerjiSK, GhoshR, RoyR and BanerjeeS. (2007). Deregulation and cross talk among Sonic hedgehog, Wnt, Hox and Notch signaling in chronic myeloid leukemia progression. Leukemia, 21:949–955.
36.
TanigakiK, HanH, YamamotoN, TashiroK, IkegawaM, KurodaK, SuzukiA, NakanoT and HonjoT. (2002). Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat Immunol, 3:443–450.
37.
CiofaniM and Zuniga-PfluckerJC. (2005). Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism. Nat Immunol, 6:881–888.
38.
DeschampsJ and van NesJ. (2005). Developmental regulation of the Hox genes during axial morphogenesis in the mouse. Development, 132:2931–2942.
39.
ClementsWK, KimAD, OngKG, MooreJC, LawsonND and TraverD. (2011). A somitic Wnt16/Notch pathway specifies haematopoietic stem cells. Nature, 474:220–224.
40.
TrowbridgeJJ, GuezguezB, MoonRT and BhatiaM. (2010). Wnt3a activates dormant c-Kit(-) bone marrow-derived cells with short-term multilineage hematopoietic reconstitution capacity. Stem Cells, 28:1379–1389.
41.
CopleyMR, BabovicS, BenzC, KnappDJ, BeerPA, KentDG, WohrerS, TreloarDQ, DayC, et al. (2013). The Lin28b-let-7-Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells. Nat Cell Biol, 15:916–925.
42.
HanSM, HanSH, CohYR, JangG, Chan RaJ, KangSK, LeeHW and YounHY. (2014). Enhanced proliferation and differentiation of Oct4- and Sox2-overexpressing human adipose tissue mesenchymal stem cells. Exp Mol Med, 46:e101.
LeeHM, ZhangH, SchulzV, TuckDP and ForgetBG. (2010). Downstream targets of HOXB4 in a cell line model of primitive hematopoietic progenitor cells. Blood, 116:720–730.
45.
FanR, BondeS, GaoP, SotomayorB, ChenC, MouwT, ZavazavaN and TanK. (2012). Dynamic HOXB4-regulatory network during embryonic stem cell differentiation to hematopoietic cells. Blood, 119:e139–147.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
